INDEMNIFICATION AGREEMENTIndemnification Agreement • May 29th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this day of , 2009, by and between MYRIAD PHARMACEUTICALS, INC., a Delaware corporation (the “Corporation”), and (“Agent”).
SUBLEASE AGREEMENTSublease Agreement • May 29th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
change order. The cost of any change orders that are necessary to comply with applicable building codes and other laws shall be borne by Landlord, unless such change orders are necessitated only because of (1) other change orders requested by Tenant; (2) Tenant Finish Plans; (3) changes to Tenant Finish Plans; or (4) Tenant’s early occupancy to the Building prior to substantial completion of Landlord’s Work. Any change order shall be effective only when set forth on a written change order executed by Landlord, Tenant, and the Base Building General Contractor. By approving a change order, Tenant and Landlord shall agree to a delay in Substantial Completion and to the Target Date, as specified therein, if any.
EMPLOYEE MATTERS AGREEMENT by and between MYRIAD GENETICS, INC. and MYRIAD PHARMACEUTICALS, INC. Dated as of June , 2009Employee Matters Agreement • May 29th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
EMPLOYEE MATTERS AGREEMENT (this “Agreement”), dated as of June , 2009, by and between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation (“MPI”). Each of Myriad and MPI is herein referred to as a “Party” and collectively, as the “Parties”.
TAX SHARING AGREEMENTTax Sharing Agreement • May 29th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Tax Sharing Agreement (this “Agreement”) is entered into as of June , 2009 between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation and wholly owned subsidiary of Myriad (“MPI” and together with Myriad, the “Parties”). Capitalized terms used in this Agreement and not otherwise defined herein shall have the meanings ascribed to such terms in the Separation and Distribution Agreement, dated as of the date hereof, by and between Myriad and MPI (the “Separation Agreement”).
SEPARATION AND DISTRIBUTION AGREEMENT by and between MYRIAD GENETICS, INC. and MYRIAD PHARMACEUTICALS, INC. Dated as of June __, 2009Separation and Distribution Agreement • May 29th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SEPARATION AND DISTRIBUTION AGREEMENT (including all Exhibit and Schedules hereto, the “Agreement”), dated as of June __, 2009, is entered into by and between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation (“MPI”) (each a “Party” and collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article 1 hereof.
